PIPERACILLIN / TAZOBACTAM (a) 4.5GM IN NS 100 ML, (b)18GM IN NS 267M, (c) 27GM IN NS 400ML, (d) 3...

FDA Recall #D-0315-2023 — Class II — December 27, 2022

Recall #D-0315-2023 Date: December 27, 2022 Classification: Class II Status: Terminated

Product Description

PIPERACILLIN / TAZOBACTAM (a) 4.5GM IN NS 100 ML, (b)18GM IN NS 267M, (c) 27GM IN NS 400ML, (d) 3.375 GM IN NS 50ML, (e) 36 GM IN NS 533 ML, antibiotic, Rx only, use with a Curlin or home pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320

Reason for Recall

Lack of sterility assurance

Recalling Firm

Sentara Infusion Services — Chesapeake, VA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

78 bags

Distribution

Dispensed to Patients Nationwide.

Code Information

Beyond Use Date: December 25-31, 2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated